Lauren Sauvageau
Medical · Lockport, NYNPI 1922617414
Payments from drug & device makers
Across 95 payments — averaging $20.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$626
- Novo Nordisk$452
- AbbVie$123
- GSK$104
- Boehringer Ingelheim$82
- Lilly USA, LLC$79
- plus $470 from 13 others
What the payments were for
- Food & beverage$1,937100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 12 | $626 |
| Novo Nordisk | 35 | $452 |
| AbbVie | 6 | $123 |
| GSK | 6 | $104 |
| Boehringer Ingelheim | 5 | $82 |
| Lilly USA, LLC | 4 | $79 |
| Exact Sciences | 4 | $71 |
| Pfizer | 4 | $68 |
| Johnson & Johnson | 3 | $67 |
| GE HealthCare | 4 | $52 |
| Phathom Pharmaceuticals, Inc. | 3 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| Seqirus USA Inc | 1 | $23 |
| Inspire Medical Systems, Inc. | 1 | $22 |
| Amgen | 1 | $19 |
| Merck | 1 | $18 |
| Kaleo, Inc. | 1 | $16 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,937 in reported general payments places this provider in the 75th percentile of 2,395 medical providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 73 | $74,293 |
| OzempicSemaglutide | 55 | $69,812 |
| JardianceEmpagliflozin | 66 | $69,153 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 61 | $46,609 |
| RybelsusSemaglutide | 15 | $23,344 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 34 | $21,943 |
| XareltoRivaroxaban | 12 | $18,910 |
| TrulicityDulaglutide | 16 | $18,393 |
| MounjaroTirzepatide | 11 | $11,082 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 15 | $4,630 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 24 | $4,410 |
| Atorvastatin Calcium | 256 | $3,645 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 58 | $3,125 |
| Levothyroxine Sodium | 189 | $2,897 |
| Metoprolol Succinate | 126 | $2,246 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $452 | $93,15670 claims |
| PfizerEliquis | $68 | $74,29373 claims |
| Boehringer IngelheimJardiance | $82 | $69,15366 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $104 | $68,55295 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $79 | $29,47527 claims |
| Johnson & JohnsonXarelto | $67 | $18,91012 claims |
| AbbVieSynthroid | $123 | $1,39227 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,395 medical providers in New York.
Other medical in Lockport
- Rebecca EllwoodAlbany$565K
- Denisse SerranoCortlandt Manor$255K
- Michele Kissous-HuntNew York$246K
- Laura MaroldoNew York$126K
- Carl ClarkeBrooklyn$116K
- Maureen ThyneNew York$109K
- Gina FriesRochester$106K
- Ilse StraussSmithtown$87K
- Helen AdamsNew York$87K
- Hailey BrickmanNew York$82K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.